abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Other Income/Expenses (Net)
-$9.55M
TTM · Period ending: · USD
HQL Other Income/Expenses (Net)
Latest reported-$9.55Mperiod ending
Latest reported-$9.55Mperiod ending
HQL Other Income/Expenses (Net) ($23.28M → -$9.55M)
Annual Other Income/Expenses (Net)
High-resolution chart · PNG
HQL other income/expenses (net) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 0 | |
| 87,216,806 | |
| 27,596,295 | |
| 2,417 | |
| -7,830 | |
| -11,177 | |
| -67,599,580 | |
| 32,271,340 | |
| 72,738,489 | |
| -8,120,973 | |
| 45,221,549 | |
| 93,033,034 | |
| 87,815,257 | |
| 78,913,515 | |
| 41,270,000 | |
| 12,150,000 | |
| -18,520,000 | |
| 63,170,000 | |
| 52,220,000 | |
| -20,100,000 | |
| 47,350,000 | |
| 10,230,000 | |
| 40,960,000 | |
| -47,890,000 | |
| -93,090,000 | |
| -28,630,000 | |
| 16,720,000 | |
| 23,280,000 |